Algeria has called for the international classification of certain substances, including pregabalin, that are not currently subject to international controls. The National Office for the Fight Against Drugs and Drug Addiction issued a statement Sunday detailing the request. This statement, released on Sunday, September 13, 2026, showed the urgency of the matter. Tarek Kour, Director General of the National Office for the Fight Against Drugs and Drug Addiction, made the call on behalf of Algeria. This initiative took place in Vienna, Austria, at the conclusion of the 33rd session of the Heads of National Drug Law Enforcement Agencies in Africa. The request notes Algeria’s proactive stance in addressing emerging challenges in drug control and its commitment to international cooperation.
Pregabalin's Growing Threat
The proposal from Algeria arrives as pregabalin continues to spread in several countries, including Algeria itself. The National Office for the Fight Against Drugs and Drug Addiction stated that the substance is not currently classified among those subject to international control. This lack of international classification presents significant challenges for law enforcement and public health authorities. "As the substance is not currently classified among those subject to international control, the risks of its diversion from therapeutic purposes are increasing, with serious consequences for individuals and society as a whole," the office said. The growing spread of pregabalin and its non-medical use has become a pressing concern for national authorities. Algeria specifically requested the inclusion of illicit trafficking in pregabalin and its non-medical use on the agenda for the next session of the Heads of African National Drug Law Enforcement Agencies. This move aims to foster a concerted regional response to the escalating issue. The risks associated with pregabalin's diversion from therapeutic uses are reportedly increasing, necessitating a more strong international framework for its control. The substance, originally intended for medical applications, is now frequently misused, leading to severe public health and safety implications across the continent.
Algeria's Regional Initiative
Algeria seeks to strengthen the exchange of knowledge and expertise among African countries as part of its initiative. The country also aims to intensify information-sharing on illicit pregabalin trafficking routes and patterns of misuse. This collaborative approach is deemed essential for effectively combating the transnational nature of drug trafficking. A key objective is to mobilize African support for the development of a joint approach to tackling the phenomenon of illicit pregabalin trade. The initiative intends to formulate practical recommendations and measures at the national, regional, and international levels to address the issue. These recommendations would encompass strategies for prevention, law enforcement, and treatment. Algeria reaffirms its commitment to combating the illicit trafficking of psychoactive substances. The nation also reiterates its dedication to strengthening joint African action in addressing emerging challenges in this field. This commitment extends to fostering greater collaboration among African nations to develop full and sustainable solutions. The proposed measures are designed to create a unified front against the illicit trade and misuse of pregabalin, ensuring a more secure environment for communities.
Diplomatic Engagement in Vienna
Algeria’s Permanent Representative to the United Nations Office and other international organizations in Vienna, Ambassador Rachid Bladehane, received the Algerian delegation. Ambassador Bladehane’s reception of the delegation marked a significant diplomatic engagement, showing Algeria's commitment to advancing its proposals on drug control within international forums. The delegation's presence in Vienna for the 33rd session of the Heads of National Drug Law Enforcement Agencies in Africa facilitated these discussions. The diplomatic efforts in Vienna aimed to garner international support for Algeria's call for the reclassification of pregabalin. The discussions provided a platform for Algeria to present its findings and concerns regarding the rising illicit trade and non-medical use of the substance. This engagement is key for building consensus among member states and international organizations on the necessity of stronger regulatory measures. The active participation of Algerian representatives in such high-level meetings demonstrates the country's leadership role in regional and international drug control efforts.
